Modification of cardiac subcellular remodeling due to pressure overload by captopril and losartan

Clinical and Experimental Hypertension

Volumn 21, Issue 1-2, 1999, Pages 145-156

  Liu, X ^a   Sentex, E ^a   Golfman, L ^a   Takeda, S ^a   Osada, M ^a   Dhalla, N S ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Cardiac gene expression; Cardiac hypertrophy; Heart function; Myofibrillar ATPase; Sarcoplasmic reticular Ca2+ pump

Indexed keywords

CAPTOPRIL; LOSARTAN;

ANIMAL EXPERIMENT; CALCIUM TRANSPORT; CONFERENCE PAPER; DRUG EFFECT; HEART HYPERTROPHY; HEART VENTRICLE PRESSURE; HYPERTENSION; NONHUMAN; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SARCOPLASMIC RETICULUM;

EID: 0032968820     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969909068657     Document Type: Conference Paper

References (33)

1. Iyer, S.N., Lu D., Katovich, M.J., Raizeda, M.K. Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type I receptor antisense. Proc Nat Acad Sci. 1996; 93: 9060-9065.
2. Cruickshank, J.M., Lewis, J., Moore, V., Dodd, C. Reversbility of left ventricular hypertrophy by differing types of antihypertensive therapy. J Hum Hypertens. 1992; 6: 161-172.
3. Dunn, F.G., Oigman, W., Ventura, H.O., Messeuli, F.H., Kobrin, I., Frohlich, E.D. Enalapril improves systemic and renal hemodynamic and allows regression of left ventricular mass in essential hypertension. Am J Cardiol. 1984; 53: 105-108.
4. Linz, W., Schoelkins, W., Ganten, D. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exp Hypertens. 1989; 11: 1325-1350.
5. Bohm, M., Castelliano, M., Agabiti-Rosei, E., Flesch, M., Paul, M., Erdman, E. Dose-dependent dissociation of ACE-inhibitor effects on blood pressure, cardiac hypertrophy and β-adrenergic signal transduction. Circulation. 1995; 92: 3006-3013.
6. Ruzicka, M., Leenen, F.H.H. Relevance of blockade of cardiac and circulatory angiotensin-converting enzyme for the prevention of volume overload-induced cardiac hypertrophy. Circulation. 1995; 91: 16-19.
7. Makino, N., Hata, T., Sugano, M., Dixon, I.M.C., Yanaga, T. Regression of hypertrophy after myocardial infarction is produced by the chronic blockade of angiotensin type I receptor in rats. J Mol Cell Cardiol. 1996; 28: 507-517.
8. Zolk, O., Flesch, M., Schnabel, P., Teisman, A.C., Pinto, Y.M., van Gilst, W.K., Paul, M., Bohm, M. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and β-adrenergic neuroeffector mechanisms in transgenic (mREN2) rats. Br J Pharmacol. 1998; 123: 405-412.
9. Wikman-Coffelt, J., Parmley, W.W., Mason, D.T. The cardiac hypertrophy process. Analyses of factor determining pathological vs physiological development. Circ Res. 1979; 45: 697-707.
10. Dhalla, N.S., Heyliger, C.E., Beamish, R.E., Innes, I.R. Pathophysiological aspect of myocardial hypertrophy. Can J Cardiol. 1987; 3: 183-196.
11. 2+-binding in hypertrophied heart. Can J Cardiol. 1985; 1: 328-339.
12. Heyliger, C.E., Ganguly, P.K., Dhalla, N.S. Sarcoplasmic reticular and mitochondrial calcium transport in cardiac hypertrophy. Can J Cardiol. 1985; 1: 401-408.
13. 2+-ATPase activities in hypertrophied heart. J Appl Cardiol. 1986; 1: 447-467.
14. Ito, Y., Suko, J., Chidsey, C.A. Intracellular calcium and myocardial contractility. V. Calcium uptake of sarcoplasmic reticulum fractions in hypertrophied and failing hearts. J Mol Cell Cardiol. 1974; 6: 237-247.
15. Lamers, J.M.J., Stinis, J.T. Defective calcium pump in the sarcoplasmic reticulum of the hypertrophied rabbit. Life Sci. 1979; 24: 2313-2320.
16. Limas, C.J., Spier, S.S., Kahlon, J. Enhanced calcium transport by sarcoplasmic reticulum in mild cardiac hypertrophy. J Mol Cell Cardiol 1980; 12: 1103-1116.
17. Sordahl, L.A., McCollum, W.B., Wood, W.G., Schwartz, A. Mitochondria and sarcoplasmic reticulum functions in cardiac hypertrophy and failure. Am J Physiol. 1973; 224: 497-502.
18. Mercadier, J.J., Swynghedauw, B., Schwartz, K. Myosin isoenzymic changes in several models of rat cardiac hypertrophy. Circ Res. 1981; 49: 525-532.
19. Alpert, N., Mulieri, L.A. Heart mechanics and myosin ATPase in normal and hypertrophied heart muscle. Fed Proc. 1982; 41: 192-198.
20. Rupp, H. The adaptive changes in the isoenzymic pattern of myosin from hypertrophied rat myocardium as a result of pressure overload and physical training. Basic Res Cardiol. 1981; 76: 79-88.
21. Rupp, H., Elimban, V., Dhalla, N.S. Modification of subcellular organelles in pressure overloaded heart by etomoxir, a carnitine palmitoyltransferase I inhibitor. FASEB J. 1992; 6: 2349-2353.
22. Zarain-Herzberg, A., Rupp, H., Elimban, V., Dhalla, N.S. Modification of sarcoplasmic reticulum gene expression in pressure overload cardiac hypertrophy by etomoxir. FASEB J. 1996; 10: 1303-1309.
23. Hiramatsu, Y., Ohkusa, T., Kihara, Y., Uegama, T., Yano, M., Sasayama, S., Matsuzaki, M. Early changes in the functions of cardiac sarcoplasmic reticulum in volume-overloaded cardiac hypertrophy in rats. J Mol Cell Cardiol. 1997; 29: 1097-1109.
24. Dhalla, N.S., Heyliger, C.E., Shah, K.R., Sethi, R., Takeda, N., Nagano, M. Remodeling of membrane systems during the development of cardiac hyertrophy due to pressure overload. In: The Adapted Heart, ed. by M. Nagano, N. Takeda, N.S. Dhalla, Raven Press, New York, 1994; pp. 27-49.
25. Ju, H., Scammell-LaFleur, T., Dixon, I.M.C. Altered mRNA abundance of calcium transport genes in cardiac myocytes in induced by angiotensin II. J Mol Cell Cardiol. 1996; 28: 1119-1128.
26. Dixon, I.M.C., Lee, S.-L., Dhalla, N.S. Nitrendipine binding in congestive heart failure due to myocardial infarction. Circ Res. 1990; 66: 782-788.
27. Pierce, G.N., Dhalla, N.S. Mechanisms of the defect in cardiac myofibrillar function during diabetes. Am J Physiol. 1985; 248: E170-E175.
28. Ganguly, P.K., Pierce, G.N., Dhalla, N.S. Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol. 1983; 244: E528-E535.
29. Osada, M., Netticadan, T., Tamura, K., Dhalla, N.S. Modification of ischemia-reperfusion-induced changes in cardiac sarcoplasmic reticulum by preconditioning. Am J Physiol. 1998; 274: H2034-H2035.
30. Chomczynski, P., Sacchi, N. Single-step method for RNA isolation by acid guamdinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162: 152-159.
31. 2+-handling in normal and failing hearts. Exp Clin Cardiol. 1996; 1: 7-20.
32. Schaub, M.C., Hefti, M.A. Zeuling, R.A., Marano, I. Modulation of contractility in human cardiac hypertrophy by myosin essential light chain isoforms. Cardiovasc Res. 1997; 37: 381-404.
33. 2+-ATPase expression in the sarcoplasmic reticulum in hypertensive cardiomyopathy. J Hypertens. 1997; 15: 1001-1009.